Coeptis Therapeutics Holdings, Inc. (COEP)
NASDAQ: COEP · Real-Time Price · USD
11.96
+0.15 (1.23%)
Feb 5, 2025, 9:41 AM EST - Market open
COEP Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
7
Market Cap
24.58M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
Novartis AG | 51.72B |
AstraZeneca | 51.21B |
Thermo Fisher Scientific | 42.88B |
Abbott Laboratories | 41.95B |
COEP News
- 6 days ago - Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation - PRNewsWire
- 13 days ago - Coeptis Therapeutics Leverages Artificial Intelligence and Blockchain for Next-Generation Innovation - PRNewsWire
- 14 days ago - Coeptis Therapeutics Regains Compliance with Nasdaq Listing Rule 5550(a)(2) - PRNewsWire
- 4 weeks ago - Coeptis Therapeutics Announces First Customer Adoptions of its NexGenAI Marketing Platform - PRNewsWire
- 5 weeks ago - Coeptis Therapeutics Announces Reverse Stock Split - PRNewsWire
- 5 weeks ago - Coeptis Therapeutics Makes Bold Strides in Innovation with the Acquisition of NexGenAI Affiliates Network Platform and Launch of Coeptis Technologies - PRNewsWire
- 7 weeks ago - Coeptis Therapeutics Unveils New Technology Division: Coeptis Technologies - PRNewsWire
- 2 months ago - Coeptis Therapeutics Executes Binding Letter of Intent to Acquire Ai-powered Marketing Solutions for Biotech, Pharmaceutical and Other Industries - PRNewsWire